BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3106021)

  • 1. Lipoxygenase inhibitors reduce insulin secretion without impairing calcium mobilization.
    Metz SA
    Endocrinology; 1987 Jun; 120(6):2534-46. PubMed ID: 3106021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade by lipoxygenase inhibitors of Ca2+-dependent insulin secretion from permeabilized rat islets. A molecular mechanism distinct from that of alpha 2-adrenergic agonists.
    Metz SA
    Biochem Pharmacol; 1989 Jun; 38(11):1849-62. PubMed ID: 2567595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of exogenous phospholipase A2 on insulin secretion from perifused rat islets.
    Zawalich W; Zawalich K
    Diabetes; 1985 May; 34(5):471-6. PubMed ID: 3921420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous arachidonic acid promotes insulin release from intact or permeabilized rat islets by dual mechanisms. Putative activation of Ca2+ mobilization and protein kinase C.
    Metz SA
    Diabetes; 1988 Nov; 37(11):1453-69. PubMed ID: 3141235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epinephrine impairs insulin release by a mechanism distal to calcium mobilization. Similarity to lipoxygenase inhibitors.
    Metz SA
    Diabetes; 1988 Jan; 37(1):65-73. PubMed ID: 2446939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mobilization of Ca2+ from intracellular stores of pancreatic beta-cells by the calcium store blocker TMB-8.
    Pian-Smith MC; Yada T; Yaney GC; Abdel el Motal SM; Wiedenkeller DE; Sharp GW
    Endocrinology; 1988 Oct; 123(4):1984-91. PubMed ID: 3046929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arachidonic acid metabolism in isolated pancreatic islets. III. Effects of exogenous lipoxygenase products and inhibitors on insulin secretion.
    Turk J; Colca JR; McDaniel ML
    Biochim Biophys Acta; 1985 Mar; 834(1):23-36. PubMed ID: 3919770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoxygenase inhibitors and cyclic AMP-mediated insulin secretion caused by forskolin, theophylline and dibutyryl cyclic AMP.
    Yamamoto S; Nakadate T; Uzumaki H; Kato R
    J Pharmacol Exp Ther; 1985 Apr; 233(1):176-80. PubMed ID: 2984411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dantrolene-induced inhibition of insulin release. A mechanism independent of effects on calcium fluxes.
    Metz SA
    Biochem Pharmacol; 1988 Jun; 37(11):2237-45. PubMed ID: 2454111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arachidonic acid metabolism in isolated pancreatic islets. IV. Negative ion-mass spectrometric quantitation of monooxygenase product synthesis by liver and islets.
    Turk J; Wolf BA; Comens PG; Colca J; Jakschik B; McDaniel ML
    Biochim Biophys Acta; 1985 Jun; 835(1):1-17. PubMed ID: 3924104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat neutrophil activation and effects of lipoxygenase and cyclooxygenase inhibitors.
    Ward PA; Sulavik MC; Johnson KJ
    Am J Pathol; 1984 Aug; 116(2):223-33. PubMed ID: 6087668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipoxygenase pathway in islet endocrine cells. Oxidative metabolism of arachidonic acid promotes insulin release.
    Metz S; VanRollins M; Strife R; Fujimoto W; Robertson RP
    J Clin Invest; 1983 May; 71(5):1191-205. PubMed ID: 6406544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Possible role of phospholipase A2 action and arachidonic acid metabolism in angiotensin II-mediated aldosterone secretion.
    Kojima I; Kojima K; Rasmussen H
    Endocrinology; 1985 Sep; 117(3):1057-66. PubMed ID: 3926464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of arachidonic acid-induced Ca2+ mobilization from rat liver microsomes.
    Chan KM; Turk J
    Biochim Biophys Acta; 1987 Apr; 928(2):186-93. PubMed ID: 3105593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of lipoxygenase metabolites of arachidonic acid in the regulation of adrenocorticotropin secretion by perifused rat anterior pituitary cells.
    Won JG; Orth DN
    Endocrinology; 1994 Oct; 135(4):1496-503. PubMed ID: 7523100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Arachidonate stimulates prolactin release in vitro: a role for the fatty acid and its metabolites as intracellular regulator(s) in mammotrophs.
    Canonico PL; Judd AM; Koike K; Valdenegro CA; MacLeod RM
    Endocrinology; 1985 Jan; 116(1):218-25. PubMed ID: 2981065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role for the lipoxygenase pathway of arachidonic acid metabolism in glucose- and glucagon-induced insulin secretion.
    Metz SA; Fujimoto WY; Robertson RP
    Life Sci; 1983 Feb; 32(8):903-10. PubMed ID: 6298551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of putative inhibitors on cytosolic and membrane associated platelet lipoxygenase.
    Rao GH; Kishore NP; White JG
    Prostaglandins Leukot Med; 1987 Mar; 26(3):281-90. PubMed ID: 3106988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Putative roles for lysophospholipids as mediators and lipoxygenase-mediated metabolites of arachidonic acid as potentiators of stimulus-secretion coupling: dual mechanisms of p-hydroxymercuribenzoic acid-induced insulin release.
    Metz SA
    J Pharmacol Exp Ther; 1986 Sep; 238(3):819-32. PubMed ID: 3018222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of Ca2+ mobilizing action of arachidonic acid in human platelets.
    Tohmatsu T; Nakashima S; Nozawa Y
    Biochim Biophys Acta; 1989 Jun; 1012(1):97-102. PubMed ID: 2499358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.